维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

18篇 您的检索式：作者名="Maraveyas"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Chemotherapy plus percutaneous radiofrequency ablation in patients with inoperable colorectal liver metastases显示文摘AIM:To access the efficacy of chemotherapy plus radiofrequency ablation(RFA)as one line of treatment in inoperable colorectal liver metastases.METHODS:Eligible patients were included in three PhaseⅡstudies.In the first study percutaneous RFA was used first followed by 6 cycles of 5-fluorouracil,leucovorin and irinotecan combination(FOLFIRI)(adjunctive chemotherapy trial).In the other two,chemotherapy(FOLFIRI or 5-fluorouracil,leucovorin and oxaliplatin combination)up to 12 cycles was used first with percutaneous RFA offered to responding patients (primary chemotherapy trials).RESULTS:Thirteen patients were included in the adjunctive chemotherapy trial and 17 in the other two.At inclusion they had 1-4 liver metastases(up to 6.5 cm in size).Two patients died during chemotherapy.All patients in the adjunctive chemotherapy trial and 44%in the primary chemotherapy studies had their metastases ablated.Median PFS and overall survival in the adjunctive study were 13 and 24 mo respectively while in the primary chemotherapy studies they were 10 and 21 mo respectively.Eighty one percent of the patients had tumour relapse in at least one previously ablated lesion.CONCLUSION:Chemotherapy plus RFA in patients with low volume inoperable colorectal liver metastases seems safe and relatively effective.The high local recurrence rate is of concern.	Joseph Sgouros James Cast Krishna K Garadi Maria Belechri David J Breen John RT Monson Anthony Maraveyas	2011	World Journal of Gastrointestinal Oncology2011，3，4：	4
	2	Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer显示文摘	A. Maraveyas J. Waters R. Roy D. Fyfe D. Propper F. Lofts J. Sgouros E. Gardiner K. Wedgwood C. Ettelaie G. Bozas	2011	European Journal of Cancer2011，，9：	1
	3	Diagnosis and manage- ment of people with venous thromboembolism and advanced can- cer: how do doctors decide? A qualitative study显示文摘	Johnson MJ Sheard L Maraveyas A	2012	BMC Med In- form Decis Mak2012，12，1：	1
	4	Weight-adjusted dalteparin for prevention of vascular thromboembolism in advanced pancreatic cancer patients decreases serum tissue factor and serummediated induction of cancer cell invasion显示文摘	Maraveyas A Ettelaie C Echrish H	2010	Blood Coagul Fibrinolysis2010，21，5：	1
	5	Gemcitabine with or without prophylactic weight-adjusted dalteparin in patients with advanced or metastatic pancreatic cancer (APC) :a mul ticentre, randomised phase IIB trial (the UK FRAGEM stud- y) 显示文摘	Maraveyas A Waters J Roy R	2009	European Journal of Cancer Supplements2009，7，2：	1
	6	Selective internal radiation in the tumor显示文摘	Maraveyas A Kosmas C Hird V	1994	Front Radiat Oncol1994，24，：	1
	7	Possible improved survival of patients with stage Ⅳ AJCC melanoma receiving SRL 172 immunotherapy: correlation with induction of increased levels of intracellular interleukin-2 in peripheral blood lymphocytes 显示文摘	Maraveyas A Baban B Kennard D	1999	Ann Oncol1999，10，7：	1
	8	Gemcitabine with or without prophylactic weight-adjusted dalteparin in patients with adavnced or metastatic pancreatic cancer (APC):a multicentre,randomised phase Ⅱ B trial(the UK FRAGEM study)显示文摘	Maraveyas A Waters J Roy R	2009	EJC Suppl2009，7，：	1
	9	Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer显示文摘	Maraveyas A Waters J Roy R	2012	Eur J Cancer2012，48，9：	1
	10	Possible improved survival of patients with Stage IV AJCC melanoma receiving SRL172 immunotherapy: correlation with induction of increased levels of intracellular interleukin-2 in PBLCs显示文摘	Baban B Kennard D	1999	Ann Oncol1999，10，：	1
	11	Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: correlation with induction of increased of intracellular interleukin-2 in peripheral blood lymphocytes显示文摘	Baban B Kennard D	1999	Ann Oncol1999，10，：	1
	12	Chemotherapy for colorectal cancer显示文摘	Goyle S Maraveyas A	2005	Dig Surg2005，22，6：	1
	13	Malignant melanoma as a target malignancy for the study of the antimetastatic properties of the heparins 显示文摘	Maraveyas A Johnson M J Xiao YP	2010	Cancer Metastasis Rev2010，29，4：	1
	14	Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer显示文摘	A. Maraveyas J. Waters R. Roy D. Fyfe D. Propper F. Lofts J. Sgouros E. Gardiner K. Wedgwood C. Ettelaie G. Bozas	2011	European Journal of Cancer2011，，：	1
	15	Malignant melanoma asa target malignancy for the study of the anti-metastatic propertiesof the heparins 显示文摘	Maraveyas A Johnson MJ Xiao YP	2010	Cancer Metastasis Rev2010，29，4：	1
	16	Anti-chelate antibodies after intraperitoneal yttrium-90-labeled monoclonal antibody immunoconjugates for ovarian cancer therapy 显示文摘	Kosmas C Maraveyas A Gooden CS	1995	J Nucl Med1995，36，5：	1
	17	恶性肿瘤研究动态显示文摘关于2。	Michael A Hill M Maraveyas A 兰玲(摘译) 林万隆(审校)	2007	世界肿瘤杂志2007，6，3：	0
	18	Pancreatic cancer:A model cancer for the study of the therapeutic effects of anticoagulants显示文摘Cancer-related thromboembolic disease is a well recognized syndrome since first described by Armand Trousseau in 1865.Preventing the morbidity and mortality related to thromboembolism in these patients is becoming a priority research area with the advent of new anti-coagulants.It is only recently that randomized trials of improved quality are been undertaken to study this question.Many of these trials however are still not accounting for the heterogeneity of 'cancer' in terms of anatomical site,histology,stage and treatment.This editorial review highlights why pancreatic cancer may serve as a model malignancy to study this question.	Anthony Maraveyas	2009	World Journal of Gastrointestinal Oncology2009，1，1：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费